Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to assess whether, in GnRH agonist in vitro fertilization (IVF) cycles, where there is a risk of ovarian hyperstimulation syndrome (OHSS), the addition of cabergoline to the hydroxyethyl starch infusion could decrease OHSS incidence and severity.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hospital de Cruces
• Treatments: Cabergoline; Hydroxyethyl Starch Derivatives

Criteria

Inclusion Criteria:

• to be at risk of OHSS were invited to participate in the study

Exclusion Criteria:

• age > 40 years